Search bioRxivSearch

Biology subjects

Gillespie, A.

Publications and source records attributed to Gillespie, A..

2 recordsLinked to original sources

Identification of leptospiral protein antigens recognized by WC1+ γδ T cell subsets as target for development of recombinant vaccines

Pathogenic Leptospira species cause leptospirosis, a neglected zoonotic disease recognized as a global public health problem. It is also the cause of the most common cattle infection that results in major economic losses due to reproductive problems. {gamma}{delta} T cells play a role in the protective immune response in livestock species against Leptospira while human {gamma}{delta} T cells also respond to Leptospira. Thus, activation of {gamma}{delta} T cells has emerged as a potential component for optimization of vaccine strategies. Bovine {gamma}{delta} T cells proliferate and produce IFN-{gamma} in response to vaccination with inactivated leptospires and this response is mediated by a specific subpopulation of the WC1-bearing {gamma}{delta} T cells. WC1 molecules are members of the group B scavenger receptor cysteine rich (SRCR) superfamily and are composed of multiple SRCR domains, of which particular extracellular domains act as ligands for Leptospira. Since WC1 molecules function as both pattern recognition receptors and {gamma}{delta} TCR coreceptors, the WC1 system has been proposed as a novel target to engage {gamma}{delta} T cells. Here, we demonstrate the involvement of leptospiral protein antigens in the activation of WC1+ {gamma}{delta} T cells and identified two leptospiral outer membrane proteins able to interact directly with them. Interestingly, we show that the protein-specific {gamma}{delta} T cell response is composed of WC1.1+ and WC1.2+ subsets, although a greater number of WC1.1+{gamma}{delta} T cells respond. Identification of protein antigens will enhance our understanding of the role {gamma}{delta} T cells play in the leptospiral immune response and in recombinant vaccine development.

immunology

Large-scale analysis of DNA methylation identifies cellular alterations in blood from psychosis patients and molecular biomarkers of treatment-resistant schizophrenia.

ObjectivePsychosis - a complex and heterogeneous neuropsychiatric condition characterized by hallucinations and delusions - is a common feature of schizophrenia. There is evidence for altered DNA methylation (DNAm) associated with schizophrenia in both brain and peripheral tissues. We aimed to undertake a systematic analysis of variable DNAm associated with psychosis, schizophrenia, and treatment-resistant schizophrenia, also exploring measures of biological ageing, smoking, and blood cell composition derived from DNAm data to identify molecular biomarkers of disease. MethodsWe quantified DNAm across the genome in blood samples from 4,483 participants from seven case-control cohorts including patients with schizophrenia or first-episode psychosis. Measures of biological age, cellular composition and smoking status were derived from DNAm data using established algorithms. DNAm and derived measures were analyzed within each cohort and the results combined by meta-analysis. ResultsPsychosis cases were characterized by significant differences in measures of blood cell proportions and elevated smoking exposure derived from the DNAm data, with the largest differences seen in treatment-resistant schizophrenia patients. DNAm at 95 CpG sites was significantly different between psychosis cases and controls, with 1,048 differentially methylated positions (DMPs) identified between schizophrenia cases and controls. Schizophrenia-associated DMPs colocalize to regions identified in genetic association studies, with genes annotated to these sites enriched for pathways relevant to disease. Finally, a number of the schizophrenia associated differences were only present in the treatment-resistant schizophrenia subgroup. ConclusionsWe show that DNAm data can be leveraged to derive measures of blood cell counts and smoking that are strongly associated with psychosis. Our DNAm meta-analysis identified multiple DMPs associated with both psychosis and a more refined diagnosis of schizophrenia, with evidence for differential methylation associated with treatment-resistant schizophrenia that potentially reflects exposure to clozapine.

genomics